Alpine Associates Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Alpine Associates Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,394,098	Closed	-$12.4M	–	63
2019 Q2	$12.4M	Buy	+2,394,098	New	+$10.8M	0.36%	38

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Alpine Associates Management's PETX Position: Q3 2019 in Review

Alpine Associates Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 2,394,098 shares — an estimated $12.4M sold.

Alpine Associates Management first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $12.4M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Alpine Associates Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Alpine Associates Management sold 2,394,098 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $12.4M.
Alpine Associates Management first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Alpine Associates Management's Aratana Therapeutics, Inc. position peaked at $12.4M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Alpine Associates Management's 13F filing for Q3 2019, filed 13 Nov 2019.